Author: Sonoma Pharmaceuticals, Inc.

Posted Date:

May 3, 2026

Sonoma Pharmaceuticals Announces Pricing of $4 Million Public Offering

Sonoma Pharmaceuticals, Inc.

May 3, 2026
Sonoma Pharmaceuticals Announces Launch of New Dermatology Product Line under Person & Covey’s Aquanil Brand for Sensitive Skin

Sonoma Pharmaceuticals, Inc.

March 18, 2026
Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2026 Financial Results

Sonoma Pharmaceuticals, Inc.

February 11, 2026
Sonoma Pharmaceuticals Welcomes New Member of its Board of Directors and New Senior Vice President of Regulatory, Quality and Product Development

Sonoma Pharmaceuticals, Inc.

February 3, 2026